갑상선 자가항체와 만성 특발성 두드러기의 예후
Thyroid autoantibodies and the prognosis of chronic idiopathic urticaria
2
조회
0
다운로드
7
인용
0
참고문헌
키워드
초록
Purpose: Chronic urticaria is a common disease, but clinically, it is not easy to treat and predict the prognosis since the causes and pathophysiology of chronic urticaria remain unknown. Many studies have been done that defined the association between chronic urticaria and thyroid autoimmunity. However, the clinical role of antithyroid antibodies (ATAs) has not been fully evaluated. Methods: We retrospectively reviewed the medical records of patients with chronic urticaria and compared the duration of treatment, the frequency of steroid use, and the level of medications used in the treatment of urticaria according to the presence or absence of ATAs including the antithyroglobulin (anti-TG) antibody, antithyroid peroxidase antibody, and antithyrotropin-stimulating hormone receptor antibody. Results: A total of 194 patients with chronic urticaria was enrolled; of which, 108 patients were free of ATAs and 86 patients had at least one ATA. The treatment duration was significantly longer in the anti-TG antibody-positive patients compared to the patients without ATAs (39.6±10.2 months/18.0±3.4 months, P=0.02). The patients with the anti-TG antibody also showed more frequent steroid use than that of the patients without the anti-TG antibody (2.1±0.4/1.1±0.3, P=0.05). The level of medications used to achieve control of urticaria tended to be higher in patients with the anti-TG antibody than in the ATA-negative patients group. Conclusion: From this study, we suggest that the evaluation of thyroid autoantibodies, especially the anti-TG antibody, can be a useful tool in predicting the prognosis and making decisions for the treatment strategy of patients with chronic urticaria.
Abstract
Purpose: Chronic urticaria is a common disease, but clinically, it is not easy to treat and predict the prognosis since the causes and pathophysiology of chronic urticaria remain unknown. Many studies have been done that defined the association between chronic urticaria and thyroid autoimmunity. However, the clinical role of antithyroid antibodies (ATAs) has not been fully evaluated. Methods: We retrospectively reviewed the medical records of patients with chronic urticaria and compared the duration of treatment, the frequency of steroid use, and the level of medications used in the treatment of urticaria according to the presence or absence of ATAs including the antithyroglobulin (anti-TG) antibody, antithyroid peroxidase antibody, and antithyrotropin-stimulating hormone receptor antibody. Results: A total of 194 patients with chronic urticaria was enrolled; of which, 108 patients were free of ATAs and 86 patients had at least one ATA. The treatment duration was significantly longer in the anti-TG antibody-positive patients compared to the patients without ATAs (39.6±10.2 months/18.0±3.4 months, P=0.02). The patients with the anti-TG antibody also showed more frequent steroid use than that of the patients without the anti-TG antibody (2.1±0.4/1.1±0.3, P=0.05). The level of medications used to achieve control of urticaria tended to be higher in patients with the anti-TG antibody than in the ATA-negative patients group. Conclusion: From this study, we suggest that the evaluation of thyroid autoantibodies, especially the anti-TG antibody, can be a useful tool in predicting the prognosis and making decisions for the treatment strategy of patients with chronic urticaria.
참고문헌 (29)
- Zuberbier T, "EAACI", GA(2)LEN, WAO guideline: definition, classification and diagnosis of urticaria, pp.Allergy, 2009[DOI]
- Najib U, "The spectrum of chronic urticaria", Allergy Asthma Proc, 30, pp.1~10 (2009)
- Grattan CE, "British Association of Dermatologists Therapy Guidelines and Audit Subcommittee. Guidelines for evaluation and management of urticaria in adults and children", Br J Dermatol, 157, pp.1116~1123 (2007)
- Fernando S, "Chronic urticaria: assessment and treatment", Aust Fam Physician, 39, pp.135~138 (2010)
- Posthumus J, "Autoimmune mechanisms in chronic idiopathic urticaria", J Allergy Clin Immunol, 130, pp.814~816 (2012)
- Kulthanan K, "Chronic idiopathic urticaria: prevalence and clinical course", J Dermatol, 34, pp.294~301 (2007)
- Charlesworth EN, "Urticaria and angioedema", Allergy Asthma Proc, 23, pp.341~345 (2002)
- Eckman JA, "Basophil phenotypes in chronic idiopathic urticaria in relation to disease activity and autoantibodies", J Invest Dermatol, 128, pp.1956~1963 (2008)
- Sabroe RA, "The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria", Br J Dermatol, 140, pp.446~452 (1999)
- Levy Y, "Chronic urticaria: association with thyroid autoimmunity", Arch Dis Child, 88, pp.517~519 (2003)
- Verneuil L, "Association between chronic urticaria and thyroid autoimmunity: a prospective study involving 99 patients", Dermatology, 208, pp.98~103 (2004)
- Palma-Carlos AG, "Chronic urticaria and thyroid auto- immunity", Eur Ann Allergy Clin Immunol, 37, pp.143~146 (2005)
- Konstantinou GN, "EAACI", GA(2)LEN task force consensus report: the autologous serum skin test in urticaria, 2009, pp.64, 1256~1268
- Zuberbier T, "EAACI", GA(2)LEN, WAO guideline: management of urticaria, pp.Allergy, 2009[DOI]
- Hide M, "The pathogenesis of chronic idiopathic urticaria: new evidence suggests an auto-immune basis and implications for treatment", Clin Exp Allergy, 24, pp.624~627 (1994)
- Kaplan AP, "Chronic urticaria: pathogenesis and treatment", J Allergy Clin Immunol, 114, pp.465~474 (2004)
- Leznoff A, "Association of chronic urticaria and angioedema with thyroid autoimmunity", Arch Dermatol, 119, pp.636~640 (1983)
- Hollowell JG, "Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)", J Clin Endocrinol Metab, 87, pp.489~499 (2002)
- Engler H, "Anti-thyroid peroxidase (anti-TPO) antibodies in thyroid diseases, non-thyroidal illness and controls. Clinical validity of a new commercial method for detection of anti-TPO (thyroid microsomal) autoantibodies", Clin Chim Acta, 225, pp.123~136 (1994)
- Mariotti S, "Antithyroid peroxidase autoantibodies in thyroid diseases", J Clin Endocrinol Metab, 71, pp.661~669 (1990)
- Mozena JD, "Lack of a role for cross-reacting anti-thyroid antibodies in chronic idiopathic urticaria", J Invest Dermatol, 130, pp.1860~1865 (2010)
- Bagnasco M, "Urticaria and thyroid autoimmunity", Thyroid, 21, pp.401~410 (2011)
- Leznoff A, "Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patients", J Allergy Clin Immunol, 84, pp.66~71 (1989)
- Ryhal B, "Are autoantibodies present in patients with subacute and chronic urticaria?", J Investig Allergol Clin Immunol, 11, pp.16~20 (2001)
- Zauli D, "Thyroid autoimmunity in chronic urticaria", Allergy Asthma Proc, 22, pp.93~95 (2001)
- Kikuchi Y, "Antithyroid antibodies in chronic urticaria and angioedema", J Allergy Clin Immunol, 112, pp.218~ (2003)
- Fernandez Romero DS, "Chronic urticaria with alterations of the thyroid function and thyroid peroxidase antibodies", Medicina (B Aires), 65, pp.231~234 (2005)
- Gaig P, "Successful treatment of chronic idiopathic urticaria associated with thyroid autoimmunity", J Investig Allergol Clin Immunol, 10, pp.342~345 (2000)
- Cebeci F, "Association between chronic urticaria and thyroid autoimmunity", Eur J Dermatol, 16, pp.402~405 (2006)